Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progressionAmanda L. McCormick, Devin B. Lowe|Frontiers in Immunology|2023Cited by 9